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threat of geographic expansion from emerging and tradi-
tional infectious diseases has increased. UNESCO deﬁnes
an international migrant as a person living outside their
birth country for >= 12 months. The global patterns of
human migration have changed substantially in the last
half century: 1) increased # countries sending and receiving
migrants, 2) accelerated rates of migration, 3) bi-directional
migration and migration transitions, 4) diversiﬁcation of
migrant types, and 5) changes in gender patterns of
migrants. Along with these profound changes in demography,
volume, speed, and purpose of migration come unique chal-
lenges in detection, diagnosis, response and management
of infectious diseases. Even in the 21st Century infectious
diseases account for ∼25% of the global mortality burden
as well as substantial morbidity. Increasingly these diseases
are blind to geopolitical borders. Cyclical pandemics like
inﬂuenza traverse the globe more rapidly than ever; newly
emerged pathogens like SARS represent a constant challenge
to public health preparedness and response. Even old dis-
eases like tuberculosis emerge in more lethal drugresistant
forms e.g. XDR-TB. These challenges demand new paradigms
to global disease control in governance, surveillance and
response. The 2005 International Health Regulations and a
range of newly formed international networks and partner-
ships are a testament to the challenges posed by the new
era of migration. Our success in combating these microbial
threats will depend on our collective effort to organize and
respond on ‘‘supra national’’ level.
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While the immunological correlates that contribute to
slower HIV disease progression are still unknown, epi-
demiologic data strongly suggest that particular major
histocompatibility complex (MHC) class 1 alleles (including
-B27, -B57, and others that fall within the HLA-Bw4 fam-
ily of HLA-class I B alleles) are highly enriched in subjects
who maintain undetectable viral loads in the absence of
antiretroviral therapy, Elite controllers. While these MHC
molecules interact with T-cell receptors found on cytotoxic
CD8+ T cells, they also interact with innate immune recep-
tors, such as the Killer Immunoglobulin like receptors (KIR)
found on the surface of innate cytotoxic Natural Killer (NK)
cells. Furthermore, the protective effect of MHC class I alle-
les is ampliﬁed in subjects that co-express particular KIRs,
with which they are able to interact, resulting in slower pro-
gression to AIDS in these individuals compared to those that
only possess the KIR or MHC allele alone. Thus it is plausible
that NK cells may play a central role in the control of HIV
infection. NK cells expand rapidly following acute infection,
and speciﬁc populations of KIR+ NK cells expand preferen-
tially in subjects that co-express protective KIR/MHC class 1
combinations. This speciﬁc KIR3DS1+ NK cell clonal expan-
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ion persists for up to 1 year in the peripheral circulation,
nd is associated with more aggressive containment of HIV-
iral replication in vitro, these NK cells exhibit a more
olyfunctional cytokine proﬁle, and kill MHC class 1 target
ells more more aggressively than NK cells from individuals
hat do not have the protective KIR/HLA combined geno-
ype. However, despite this early epansion of NK cells in the
eriphery, these cells do not gain access to secondary lym-
hoid organs, thus providing a safe haven within which the
irus is able to replicate unabated by the innate immune
ystem, potentially allowing the virus to establish a chronic
nfection. These data strongly suggest durable control of HIV
nfection is associated with an early aggressive deployment
f highly licensed antiviral NK cells in the periphery that
ay provide speciﬁc and non-speciﬁc control of HIV viral
eplication in acute infection, while producing large quanti-
ies of cytokines and chemokines required for the induction
f high quality adaptive immune responses that may then
aintain control of HIV replication most likely in contained
issue sites.
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The window between transmission and peak viremia,
rior to the establishment of viral reservoirs, is the narrow
ut critical period in which a HIV-1 vaccine must control
iral replication, prevent extensive CD4 T cell destruction
nd curb generalised immune activation. We recently pub-
ished the results of T cell studies in 4 patients, showing that
he ﬁrst HIV-1 speciﬁc T cells detectable just prior to peak
iremia can select for complete virus escape in as little as
4 days.
Mathematical modeling of these very rapid rates of T cell
scape showed that the contribution of CD8+ T cell mediated
illing of productively infected cells was earlier and signif-
cantly greater than previously described; calculating that
cells in acute HIV-1 kill as much as 35% of virus-infected
ells per day. These ﬁrst T cell responses often waned rapidly
ollowing virus escape leaving, or being succeeded by, T cell
esponses to epitopes that escaped slowly or were invari-
nt. Here, we present data from an additional 10 patients
hat extend these observations and demonstrate that early
apid escape from primary HIV-1-speciﬁc T cell responses
ccurs in the majority of patients studied, suggesting that
cells are major contributors to the control of viremia in
